← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #850 OF 1,000 MOST-CITED

Distinctive ID or code not recorded in batch record

FDA cited this observation 17 times across 17 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs17
BY FISCAL YEAR
FY20261
FY20251
FY20242
FY20231
FY20223
FY20211
FY20201
FY20191
FY20182
FY20174

How FDA worded it — real examples

The batch records do not record the distinctive identification number to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

KaryoLogic Inc · Durham, North Carolina · Drugs · 2025-12-19

The batch records do not record the distinctive identification number to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

Nutrix International LLC · Salt Lake City, Utah · Drugs · 2025-04-25

The batch records do not record the distinctive name of equipment to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

Exquisite Corporation · Baldwin Park, California · Drugs · 2024-08-01

The batch records do not record the distinctive identification number to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

Episciences Inc · Boise, Idaho · Drugs · 2024-01-29

The batch records do not record the distinctive code to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

Airgas USA, LLC · Lincoln Park, New Jersey · Drugs · 2023-06-21

The batch records do not record the distinctive identification number and name of equipment to identify major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

LEC Custom Products, Inc · Mississauga · Drugs · 2022-09-02

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →